| Ticker Details |
Abbott Laboratories
Abbott Laboratories is a health care company that manufactures medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs.
|
| IPO Date: |
December 24, 1981 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$175.17B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.68 | 0.97%
|
| Avg Daily Range (30 D): |
$1.49 | 1.61%
|
| Avg Daily Range (90 D): |
$1.32 | 1.41%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
5.72M |
| Avg Daily Volume (30 D): |
10.7M |
| Avg Daily Volume (90 D): |
9.82M |
| Trade Size |
| Avg Trade Size (Sh.): |
140 |
| Avg Trade Size (Sh.) (30 D): |
80 |
| Avg Trade Size (Sh.) (90 D): |
77 |
| Institutional Trades |
| Total Institutional Trades: |
103,795 |
| Avg Institutional Trade: |
$5.86M |
| Avg Institutional Trade (30 D): |
$14.15M |
| Avg Institutional Trade (90 D): |
$13.52M |
| Avg Institutional Trade Volume: |
.08M |
| Avg Institutional Trades (Per Day): |
18 |
| Market Closing Trades |
| Avg Closing Trade: |
$56.21M |
| Avg Closing Trade (30 D): |
$254.31M |
| Avg Closing Trade (90 D): |
$225M |
| Avg Closing Volume: |
676.75K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$3.59
|
$.62
|
|
|
Diluted EPS
|
$3.57
|
$.61
|
|
|
Revenue
|
$45.13B
|
$11.16B
|
|
|
Gross Profit
|
$25.39B
|
$6.27B
|
|
|
Net Income / Loss
|
$6.28B
|
$1.08B
|
|
|
Operating Income / Loss
|
$7.71B
|
$1.35B
|
|
|
Cost of Revenue
|
$19.74B
|
$4.89B
|
|
|
Net Cash Flow
|
$247M
|
$-1696M
|
|
|
PE Ratio
|
|
|
|
|
|
|